Literature DB >> 12472781

Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.

Nosratola D Vaziri1, Michael Dicus, Nathan D Ho, Laleh Boroujerdi-Rad, Ram K Sindhu.   

Abstract

BACKGROUND: Chronic renal failure (CRF) is associated with oxidative stress, the mechanism of which remains uncertain. Superoxide is the primary oxygen free radical produced in the body, NAD(P)H oxidase is the major source of superoxide production and superoxide dismutase (SOD) is responsible for removal of superoxide. We hypothesized that CRF-induced oxidative stress may be due to increased production and/or decreased dismutation of superoxide.
METHODS: Immunodetectable superoxide dismutase isoforms (Cu Zn SOD and Mn SOD), as well as, NAD(P)H oxidase (gp91 phox subunit) proteins and xanthine oxidase (XO) activity were determined in the kidney and liver of CRF (5/6 nephrectomized) and sham-operated control rats. Subgroups of animals were treated with SOD-mimetic drug, tempol and blood pressure and urinary nitric oxide metabolites (NOx) were monitored.
RESULTS: The CRF group showed marked down-regulations of CuZn SOD and Mn SOD and significant up-regulation of gp91 phox in the liver and kidney, which are among the metabolically most active tissues. In contrast, XO activity was depressed in both tissues. Arterial pressure and nitrotyrosine abundance were elevated while urinary NOx excretion was depressed, pointing to increased NO inactivation by superoxide and decreased NO availability in CRF animals. Administration of SOD-mimetic agent, tempol, for one week, ameliorated hypertension, reduced nitrotyrosine abundance and increased urinary NOx excretion in the CRF animals.
CONCLUSIONS: CRF is associated with depressed SOD and elevated NAD(P)H oxidase expression, which can contribute to oxidative stress by increasing superoxide. This is evidenced by favorable response to administration of SOD-mimetic drug, tempol, and increased nitrotyrosine that is the footprint of NO interaction with superoxide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12472781     DOI: 10.1046/j.1523-1755.2003.00702.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  93 in total

Review 1.  Measuring and regulating oxygen levels in microphysiological systems: design, material, and sensor considerations.

Authors:  Kristina R Rivera; Murat A Yokus; Patrick D Erb; Vladimir A Pozdin; Michael Daniele
Journal:  Analyst       Date:  2019-05-13       Impact factor: 4.616

2.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis.

Authors:  Lygeri P Soubassi; Theodore C Chiras; Emmanuel D Papadakis; George D Poulos; Dimitrios I Chaniotis; Ioannis P Tsapakidis; Sofia P Soubassi; Stylianos N Zerefos; Nikolaos S Zerefos; Dimitrios A Valis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Oxidative stress, superoxide production, and apoptosis of neutrophils in dogs with chronic kidney disease.

Authors:  Adriana Carolina Rodrigues Almeida Silva; Breno Fernando Martins de Almeida; Carolina Soares Soeiro; Wagner Luis Ferreira; Valéria Marçal Félix de Lima; Paulo César Ciarlini
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

5.  Influence of different concentrations of uric acid on oxidative stress in steatosis hepatocytes.

Authors:  Shi Cheng; Yan Yang; Yong Zhou; Wei Xiang; Hua Yao; Ling Ma
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

Review 6.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

7.  Regulation of oxygen utilization by angiotensin II in chronic kidney disease.

Authors:  Aihua Deng; Tong Tang; Prabhleen Singh; Chen Wang; Joe Satriano; Scott C Thomson; Roland C Blantz
Journal:  Kidney Int       Date:  2008-09-24       Impact factor: 10.612

8.  Role of Oxidative Stress in the Pathogenesis of Pancreatitis: Effect of Antioxidant Therapy.

Authors:  Lourdes Robles; Nosratola D Vaziri; Hirohito Ichii
Journal:  Pancreat Disord Ther       Date:  2013-04-01

Review 9.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

Review 10.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.